alexa Risk Of Tuberculosis Infection In Anti-tnf-α Biological Therapy | 22516
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Biowaivers, Biologics & Biosimilars

N Anusha, G Santhoshi lakshmi, S Ramam and Dhana raju
Posters: J Bioanal Biomed
DOI: 10.4172/1948-593X.S1.014
Abstract
Tuberculosis is the most prevalent infectious disease of the world. Pulmonary tuberculosis form is the most frequent. Extra pulmonary and disseminated forms are more common in immunosuppressed patients. Tuberculosis infection is diagnosed by performing tuberculin skin test and interferon-gamma assays. Isoniazid is the drug most commonly used usually for 6 months. Anti-tumor necrosis factor-α (TNF-α) biological agents, including soluble TNF-α receptors and anti-TNF-α monoclonal antibodies, are the drugs used for treating rheumatic diseases such as rheumatoid arthritis. Although etanercept and infliximab are the TNF- α drugs, but may also increase the risk of infection, especially tuberculosis (TB) infection and the risk of reactivation of TB is substantially increased so, this review is focused on the underlying mechanisms that cause the TB risk in the anti-TNF-α therapy.
Biography
N.Anusha, Pharm.D 6th year, of age 23 years doing internship in GSL hospital, from Andhra university. I have done a project on ?COMPARISON OF SAFETY AND EFFICASY OF FLUNARIZINE AND TOPIRAMATE IN MIGRAINE PATIENTS? and submitted it to Andhra university.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7